StemCell Institute Statistics
Want to see JP:7096 full AI Analyst Report?
StemCell Institute (7096) Stock Statistics & Valuation Metrics
Total Valuation
StemCell Institute has a market cap or net worth of JPY 6.56B. The enterprise value is JPY 5.75B.
- Market Cap
- JPY 6.56B
- Enterprise Value
- JPY 5.75B
Share Statistics
StemCell Institute has 10,246,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 10,246,600
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
StemCell Institute’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 3.33%.
- Return on Equity (ROE)
- 0.06
- Return on Assets (ROA)
- 0.02
- Return on Invested Capital (ROIC)
- 3.33%
- Return on Capital Employed (ROCE)
- 0.06
- Revenue Per Employee
- 24.03M
- Profits Per Employee
- 1.33M
- Employee Count
- 117
- Asset Turnover
- 0.35
- Inventory Turnover
- 20.35
Valuation Ratios
The current PE Ratio of StemCell Institute is 57.55. StemCell Institute’s PEG ratio is -1.34.
- PE Ratio
- 57.55
- PS Ratio
- 2.31
- PB Ratio
- 2.36
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- -1.34
Income Statement
In the last 12 months, StemCell Institute had revenue of 2.81B and earned 155.92M in profits. Earnings per share was 15.44.
- Revenue
- 2.81B
- Gross Profit
- 1.71B
- Operating Income
- 202.66M
- Pretax Income
- 217.79M
- Net Income
- 155.92M
- EBITDA
- 379.99M
- Earnings Per Share (EPS)
- 15.44
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
StemCell Institute pays an annual dividend of JPY 25.00, resulting in a dividend yield of ―
- Dividend Per Share
- JPY 25.00
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- 1.74%
Stock Price Statistics
- Beta
- 0.53
- 52-Week Price Change
- -20.00%
- 50-Day Moving Average
- 720.80
- 200-Day Moving Average
- 747.02
- Relative Strength Index (RSI)
- 32.42
- Average Volume (3m)
- 5,223
Important Dates
StemCell Institute upcoming earnings date is Feb 09, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 10, 2026
- Next Earnings Date
- Feb 09, 2027
- Ex-Dividend Date
- Sep 27, 2024
Financial Position
StemCell Institute as a current ratio of 1.17, with Debt / Equity ratio of 17.67%
- Current Ratio
- 1.17
- Quick Ratio
- 1.16
- Debt to Market Cap
- 0.06
- Net Debt to EBITDA
- -6.21
- Interest Coverage Ratio
- 37.20
Taxes
In the past 12 months, StemCell Institute has paid 86.78M in taxes.
- Income Tax
- 86.78M
- Effective Tax Rate
- 0.40
Enterprise Valuation
StemCell Institute EV to EBITDA ratio is 15.49, with an EV/FCF ratio of 0.00.
- EV to Sales
- 1.58
- EV to EBITDA
- 15.49
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
StemCell Institute has JPY 2.83B in cash and marketable securities with JPY 473.81M in debt, giving a net cash position of JPY 2.36B billion.
- Cash & Marketable Securities
- JPY 2.83B
- Total Debt
- JPY 473.81M
- Net Cash
- JPY 2.36B
- Net Cash Per Share
- JPY 230.35
- Tangible Book Value Per Share
- JPY 286.20
Margins
Gross margin is 59.21%, with operating margin of 3.66%, and net profit margin of 4.01%.
- Gross Margin
- 59.21%
- Operating Margin
- 3.66%
- Pretax Margin
- 4.27%
- Net Profit Margin
- 4.01%
- EBITDA Margin
- 10.18%
- EBIT Margin
- 3.66%
Analyst Forecast
The average price target for StemCell Institute is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 2.55%
- EPS Growth Forecast
- -43.06%
Scores
- Smart Score
- ―
- AI Score
- 56

